Media release
From:
The Government appears poised to allow the sale of oral tobacco and nicotine products in Aotearoa New Zealand. Evidence that these products can help people quit smoking is lacking, as is evidence of the safety of long-term use. In contrast, the safety and efficacy of nicotine replacement therapy (NRT) has been rigorously tested; NRT products are widely available in this country to help people quit smoking, as are vaping products. Flavoured nicotine products are highly addictive, appeal to youth, and are being marketed by tobacco companies as lifestyle products using online marketing. ZYN (a Philip Morris product) is being sold online in New Zealand, in apparent breach of the current law. Given Aotearoa New Zealand’s experience with youth vaping (i.e., we have the highest youth vaping rates in the world), a precautionary approach and rapid action is needed to avoid another regulatory failure.